Regulatory mechanisms of hypoxia-inducible factor 1 activity: Two decades of knowledge

被引:182
|
作者
Koyasu, Sho [1 ,2 ]
Kobayashi, Minoru [1 ]
Goto, Yoko [3 ]
Hiraoka, Masahiro [3 ]
Harada, Hiroshi [1 ,4 ]
机构
[1] Kyoto Univ, Lab Canc Cell Biol, Dept Genome Dynam, Ctr Radiat Biol, Kyoto, Japan
[2] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan
[3] Kyoto Univ, Dept Radiat Oncol & Image Appl Therapy, Grad Sch Med, Kyoto, Japan
[4] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol, Saitama, Japan
来源
CANCER SCIENCE | 2018年 / 109卷 / 03期
基金
日本科学技术振兴机构;
关键词
gene expression; hypoxia-inducible factor 1 (HIF-1); molecular mechanism; tumor hypoxia; TUMOR-SUPPRESSOR PROTEIN; TRANSCRIPTIONAL ACTIVITY; CANCER-THERAPY; FACTOR; 1-ALPHA; HIF-ALPHA; FACTOR-I; STABILIZES HIF-1-ALPHA; PROLYL; 4-HYDROXYLASES; ERYTHROPOIETIN GENE; BREAST-CANCER;
D O I
10.1111/cas.13483
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hypoxia-inducible factor 1 (HIF-1) is a transcriptional activator of various genes related to cellular adaptive responses to hypoxia. Dysfunctions in the regulatory systems of HIF-1 activity have been implicated in the pathogenesis of various diseases including malignant tumors and, thus, elucidating the molecular mechanisms underlying the activation of HIF-1 is eagerly desired for the development of novel anti-cancer strategies. The importance of oxygen-dependent and ubiquitin-mediated proteolysis of the regulatory subunit of HIF-1 (HIF-1) was first reported in 1997. Since then, accumulating evidence has shown that HIF-1 may become stable and active even under normoxic conditions; for example, when disease-associated genetic and functional alterations in some genes trigger the aberrant activation of HIF-1 regardless of oxygen conditions. We herein review the last two decades of knowledge, since 1997, on the regulatory mechanisms of HIF-1 activity from conventional oxygen- and proteolysis-dependent mechanisms to up-to-the-minute information on cancer-associated genetic and functional alteration-mediated mechanisms.
引用
收藏
页码:560 / 571
页数:12
相关论文
共 50 条
  • [1] Hypoxia-inducible factor-1: Regulatory mechanisms and drug development in stroke
    Pan, Zirong
    Ma, Guodong
    Kong, Linglei
    Du, Guanhua
    PHARMACOLOGICAL RESEARCH, 2021, 170
  • [2] Hypoxia-inducible factor-1: Regulatory mechanisms and drug therapy in myocardial infarction
    Pan, Jinyuan
    Zhang, Lei
    Li, Dongxiao
    Li, Yuan
    Lu, Mengkai
    Hu, Yuanlong
    Sun, Bowen
    Zhang, Zhiyuan
    Li, Chao
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 963
  • [3] Expression of hypoxia-inducible factor 1: Mechanisms and consequences
    Semenza, GL
    BIOCHEMICAL PHARMACOLOGY, 2000, 59 (01) : 47 - 53
  • [4] Biological Functions and Regulatory Mechanisms of Hypoxia-Inducible Factor-1α in Ischemic Stroke
    He, Qianyan
    Ma, Yinzhong
    Liu, Jie
    Zhang, Dianhui
    Ren, Jiaxin
    Zhao, Ruoyu
    Chang, JunLei
    Guo, Zhen-Ni
    Yang, Yi
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [5] Hypoxia-inducible factor 1α or hypoxia-inducible factor 2α is not required for the development and physiological function of regulatory T cells
    Lai, Ming-Zong
    Hsu, Tzu-Sheng
    Lin, Yen-Lin
    Hsieh, Wan-Chen
    CYTOKINE, 2017, 100 : 158 - 158
  • [6] HYPOXIA-INDUCIBLE FACTOR AND PHYSICAL ACTIVITY
    Calderon Velez, Juan Camilo
    IATREIA, 2007, 20 (02) : 160 - 166
  • [7] The Role of Hypoxia-Inducible Factor in the Mechanisms of Aging
    Dzhalilova, Dzhuliia Sh
    Makarova, Olga, V
    BIOCHEMISTRY-MOSCOW, 2022, 87 (09) : 995 - 1014
  • [8] The Role of Hypoxia-Inducible Factor in the Mechanisms of Aging
    Dzhuliia Sh. Dzhalilova
    Olga V. Makarova
    Biochemistry (Moscow), 2022, 87 : 995 - 1014
  • [9] The Regulatory Mechanism of Hypoxia-inducible Factor 1 and its Clinical Significance
    Yin, Chun-Li
    Ma, Yu-Jie
    CURRENT MOLECULAR PHARMACOLOGY, 2024, 17
  • [10] Antiangiogenic activity of wondonin targetting hypoxia-inducible factor 1α
    Jun, H
    Seong, Y
    Hong, S
    Park, J
    Ha, H
    Kim, Y
    Kim, K
    Shin, J
    Kim, T
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 124 (04) : A3 - A3